Topic List : Infectious Disease
Stanford opens long COVID clinic
With research showing up to 30% of COVID-19 patients experiencing lingering symptoms, Stanford Health Care treats such “long haulers” with multidisciplinary teams.
Winslow leads national COVID-19 group
A professor of medicine and former Air Force colonel, Winslow temporarily relocated to Washington to head an interagency group responding to this pandemic and preparing for the next one.
Study shows why second vaccine dose effective
Scientists scrutinized Pfizer vaccine recipients’ blood samples to learn exactly what effects the vaccine exerts on the body’s immune system.
COVID-19 vaccines prevent infection
A Stanford study finds that the mRNA vaccines, Pfizer and Moderna, offer strong protection against the California variant of the coronavirus.
Broad-spectrum vaccine may be possible
An immune system stimulant called AS03 could help vaccines protect against multiple viruses by altering the epigenome of the innate immune system.
COVID-19 antibody treatment now available
An infusion of monoclonal antibodies can ease COVID-19 symptoms and reduce complications in recently diagnosed, non-hospitalized people at high risk. Now people can refer themselves.
Evidence COVID-19 causes brain inflammation
A detailed molecular analysis of tissue from the brains of individuals who died of COVID-19 reveals extensive signs of inflammation and neurodegeneration, but no sign of the virus that causes the disease.
Promote vaccination, not herd immunity
Epidemiology expert Julie Parsonnet warns that COVID-19 vaccine hesitancy has probably made herd immunity unattainable, which makes vaccination all the more important for personal health.
Post-COVID-19 symptoms are common
More than 70% of COVID-19 patients in studies — most of whom were hospitalized — reported 84 different symptoms and signs months after they became ill.
Relman on investigating coronavirus’s origin
Microbiologist David Relman explores how the coronavirus could have emerged and why we need to know.